← Back to patent-cliff list
Alosetron Hydrochloride
Tier C — Watch / tradeAlosetron Hydrochloride
Prometheus Inc
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT3
Brand：Lotronex
Indications (approved)：Irritable bowel syndrome
Regional status
US
Approved
2000-02-09
EU
-
China
Discontinued
2009-08-31
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Alosetron Hydrochloride?
Approved indications include: Irritable bowel syndrome.
When does the Alosetron Hydrochloride patent expire?
No public expiry year is available for Alosetron Hydrochloride yet; this page updates once verified.
How do I get a quote for Alosetron Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27